PNEUMAGEN LIMITED, which recently underwent a significant reorganization to create NorthLinks Bio, has secured $34.0M in new funding. The capital arrives as the company solidifies its new identity, now directing all operations and online presence to www.northlinksbio.com. This investment underscores the strategic shift for the entity formerly known as PNEUMAGEN LIMITED.


















